PDCD1 and cancer: Having regard to 16 studies (5,622 cases, 5,450 controls) (71, 136, 150, 151, 154–163) the authors concluded that the PD-1.5 was associated with susceptibility to cancer development, with the PD-1.5 T/T genotype decreasing the overall risk (OR = 0.82).